|
First Global Conference on Cardiovascular Clinical Trials and
Pharmacotherapy - 2nd WHF Global Conference on
Cardiovascular Clinical Trials and 13th International
Society of Cardiovascular Pharmacotherapy Congress – ISCP
(October
1-3, 2004, Hong Kong)
|
|
|
|
FOREWORD
The First Gobal Conference on Cardiovascular Clinical
Trials and Pharmacotherapy was held in Hong Kong, China from October
1-2, 2004. This meeting had incorporated the 2rd World Heart Federation
Global Conference on Cardiovascular Clinical Trials and 13th
International Society of Cardiovascular Pharmacotherapy Congress. This
meeting provided a gateway for scientific exchange among scientists and
physicians from different parts of world on cardiovascular clinical
trials and pharmacotherapy.
In the recent decades, there is a significant progress in the
understanding of the pathophysiology, diagnosis and treatment of
cardiovascular diseases. The conference has provided an update on recent
findings on cardiovascular clinical trials, which is the cornerstone of
good practice of evidence-based medicine, as well as advances in new
therapies derived from the most recent drug and therapeutic discoveries.
The purpose of this proceeding is to summarize some of the selected
materials that have been presented in the Conference such that
interested individuals can obtain in-depth of review these presentations.
It is sincerely hoped that this proceeding will provide a concise
overview on recent updates and practice of cardiovascular therapies.
INDEX
Invited
Lectures
Treatment Strategy for Japanese Hypertensive Patients with
Coronary Artery Disease. Comparative Effects of Nifedipine Retard vs.
ACE-Inhibitors – Results of JMIC-B Study
C. Kawai
New Treatment of Myocarditis and Heart Failure
A. Matsumori
Effects of Cardiovascular Drugs on Uric Acid in
Cardiovascular Medicine: New Paradigm
A.J. Reyes
Antithrombotic Therapy in Atrial Fibrillation
J. Tomson and G.Y.H. Lip
Free Papers
Effects of Diacetyl-linesinine on Ion Currents in
Ventricular Myocytes
F. Cao, C.X. Huang, H. Jiang, T. Wang and X. Li
Remodeling of L-Type Calcium Current in Various Stages of
Human Atrial Fibrillation
Congxin Huang, Gang Wu, Hong Jiang, Qizhu Tang, Zhengrong Huang, Qiang Xie
and Yanhong Tang
Impairment of Quality of Life in Patients with Atrial
Fibrillation
P.-Y. Sin, H.-F. Tse, C.-W. Siu, V. Tsang, C.K.L. Lam and C.-P. Lau
Successful Pulmonary Vein Isolation Using Transvenous
Catheter Cryoablation Improves Quality-of-Life in Patients with Atrial
Fibrillation
P.-Y. Sin, H.-F. Tse, C.-W. Siu, V. Tsang, C.L.K. Lam and C.-P. Lau
EvaluAtion of Resynchronization Therapy for Heart failure
(EARTH) study
B. Thibault, F. Harel, A. Ducharme, M. White, D. Roy, J.L. Rouleau, F.
Philippon, P. Dorian, M. Dubuc, P.G. Guerra, P. Khairy, L. Macle and M.
Talajic
Utility of theLevel of Brain Natriuretic Peptide in Plasma
for the Evaluation of Cardiac Function in Chronic Left Heart Failure
Treatment with ß-Blockers
Fang Wang, Xiaoru Chen, Wei Li, Zhimin Xu and Yishi Li
Remodeling of Transient Outward Potassium Current During
Development of Human Atrial Fibrillation
Gang Wu, Congxin Huang, Zhengrong Huang, Qizhu Tang,
Hong Jiang, Qiang Xie and Yanhong Tang
Nifedipine Retard Is as Effective as ACE-I for
Hypertension in Diabetics / The JMIC-B Subgroup Analysis
Y. Yui
Nifedipine Suppresses the Progression of Coronary
Atherosclerosis / The JMIC-B Side Arm Study
Y. Yui
Mast Cells Contribute to Angiogenesis after Coronary
Microembolization
Q.-Y. Zhang, H.-F. Tse, J.-Z. Chen, Q.-G. Zhang and J.-B. Ge
Inhibitory Effect of Clopidogrel on Platelet Aggregation
in CHD Patients
Xiuli Zhao, DayiHu, jie Xiao, Hong Bian and Tianchang Li |
